Is MoonLake Immunotherapeutics halal to invest in?

According to Musaffa's Shariah screening methodology, MoonLake Immunotherapeutics (MLTX) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is MoonLake Immunotherapeutics a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes MoonLake Immunotherapeutics using these criteria to determine its compliance status.

Can Muslims buy shares of MoonLake Immunotherapeutics?

Muslim investors may consider investing in MoonLake Immunotherapeutics if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is MoonLake Immunotherapeutics classified as NOT HALAL?

Musaffa determines the Shariah status of MoonLake Immunotherapeutics by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for MoonLake Immunotherapeutics updated?

The Shariah compliance status of MoonLake Immunotherapeutics may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like MoonLake Immunotherapeutics become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of MoonLake Immunotherapeutics?

You can check the latest Shariah compliance status of MoonLake Immunotherapeutics on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MLTX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 27, 2026

Report Source: 2025 Annual Report

MoonLake Immunotherapeutics. Stock Analysis MLTX

United States Health Care Small Cap Report: 2025 Annual

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.

Key Statistics of MoonLake Immunotherapeutics (MLTX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$17.50$18.26

Today's Open

$18.26

Volume

585.57K

P/E Ratio (TTM)

52 Week Range

$5.95$62.75

Market Cap

1.24B

Avg. Volume

906.42K

Dividend Yield

Financial Metrics & Statements of MoonLake Immunotherapeutics (MLTX)

FAQ's for MoonLake Immunotherapeutics (MLTX)

According to Musaffa’s Shariah screening methodology, MoonLake Immunotherapeutics (MLTX) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.